SYRS Syros Pharmaceuticals Inc

0.04 (1.02%)
Last Updated: 14:14:11
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 11,335
Bid Price 3.91
Ask Price 3.96
News -
Day High 3.97


52 Week Range


Day Low 3.86
Company Name Stock Ticker Symbol Market Type
Syros Pharmaceuticals Inc SYRS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 1.02% 3.96 14:14:11
Open Price Low Price High Price Close Price Prev Close
3.90 3.86 3.97 3.92
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
183 11,335 $ 3.92 $ 44,413 - 2.42 - 6.95
Last Trade Time Type Quantity Stock Price Currency
14:16:27 2 $ 3.935 USD

Syros Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
82.01M 20.71M - 14.88M -94.65M -4.57 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Syros Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No SYRS Message Board. Create One! See More Posts on SYRS Message Board See More Message Board Posts

Historical SYRS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.894.033.783.9583,3290.071.8%
1 Month3.884.033.663.9358,4190.082.06%
3 Months3.084.202.873.7761,0160.8828.57%
6 Months2.824.202.423.4171,9511.1440.43%
1 Year5.676.952.423.96100,522-1.71-30.16%
3 Years9.2915.64990.654.50579,596-5.33-57.37%
5 Years11.8315.64990.655.37450,612-7.87-66.53%

Syros Pharmaceuticals Description

Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology, and other related markets that address gene control and cancer. The Company operates only in the United States.